 Karen Moulton
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Remodeling | 6 | 2022 | 193 | 1.010 |
Why?
| | Atherosclerosis | 6 | 2023 | 415 | 1.010 |
Why?
| | Coronary Vessels | 2 | 2018 | 248 | 0.990 |
Why?
| | Heart-Assist Devices | 4 | 2022 | 552 | 0.990 |
Why?
| | PTEN Phosphohydrolase | 4 | 2020 | 167 | 0.930 |
Why?
| | Neovascularization, Pathologic | 4 | 2011 | 301 | 0.830 |
Why?
| | Fibrosis | 7 | 2023 | 552 | 0.780 |
Why?
| | Myocytes, Smooth Muscle | 6 | 2023 | 261 | 0.760 |
Why?
| | Plaque, Atherosclerotic | 3 | 2023 | 57 | 0.740 |
Why?
| | Collagen Type XVIII | 2 | 2010 | 5 | 0.580 |
Why?
| | Myofibroblasts | 3 | 2023 | 127 | 0.390 |
Why?
| | Muscle, Smooth, Vascular | 6 | 2023 | 446 | 0.380 |
Why?
| | Aortic Diseases | 2 | 2021 | 119 | 0.370 |
Why?
| | Heart Failure | 3 | 2021 | 2236 | 0.350 |
Why?
| | Basement Membrane | 1 | 2010 | 35 | 0.350 |
Why?
| | Matrix Metalloproteinases | 1 | 2011 | 95 | 0.350 |
Why?
| | Hypertriglyceridemia | 1 | 2010 | 39 | 0.340 |
Why?
| | Lipoprotein Lipase | 1 | 2010 | 59 | 0.340 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2011 | 195 | 0.330 |
Why?
| | Receptors, LDL | 5 | 2023 | 47 | 0.300 |
Why?
| | Hypercholesterolemia | 2 | 2023 | 106 | 0.290 |
Why?
| | Diabetic Nephropathies | 1 | 2011 | 294 | 0.280 |
Why?
| | Apolipoproteins E | 4 | 2009 | 83 | 0.280 |
Why?
| | Vasa Vasorum | 2 | 2004 | 25 | 0.270 |
Why?
| | Mice | 19 | 2023 | 17787 | 0.260 |
Why?
| | Arteriosclerosis | 2 | 2003 | 88 | 0.230 |
Why?
| | Mice, Inbred C57BL | 10 | 2023 | 5757 | 0.230 |
Why?
| | Capillary Permeability | 1 | 2004 | 145 | 0.210 |
Why?
| | Gene Expression | 2 | 2022 | 1502 | 0.210 |
Why?
| | Animals | 20 | 2023 | 36940 | 0.200 |
Why?
| | Spinocerebellar Ataxias | 1 | 2022 | 6 | 0.190 |
Why?
| | Vascular System Injuries | 1 | 2023 | 71 | 0.190 |
Why?
| | Mice, Knockout | 8 | 2016 | 3015 | 0.190 |
Why?
| | Genes, X-Linked | 1 | 2022 | 18 | 0.190 |
Why?
| | X Chromosome Inactivation | 1 | 2022 | 25 | 0.190 |
Why?
| | Cell Differentiation | 6 | 2023 | 1991 | 0.190 |
Why?
| | Aortic Valve Insufficiency | 1 | 2022 | 47 | 0.190 |
Why?
| | Aortic Valve | 2 | 2022 | 351 | 0.190 |
Why?
| | Assisted Circulation | 1 | 2021 | 26 | 0.180 |
Why?
| | Lipoproteins | 2 | 2014 | 168 | 0.180 |
Why?
| | Gene Expression Regulation | 5 | 2022 | 2607 | 0.180 |
Why?
| | Macrophages | 5 | 2007 | 1547 | 0.170 |
Why?
| | Receptors, Lipoprotein | 3 | 1995 | 6 | 0.170 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 17 | 0.170 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 66 | 0.170 |
Why?
| | Actins | 2 | 2022 | 416 | 0.160 |
Why?
| | Peptide Fragments | 2 | 2003 | 706 | 0.150 |
Why?
| | Tunica Intima | 1 | 1999 | 84 | 0.150 |
Why?
| | Sesquiterpenes | 1 | 1999 | 55 | 0.150 |
Why?
| | Receptors, Immunologic | 3 | 1995 | 216 | 0.150 |
Why?
| | High-Throughput Screening Assays | 1 | 2020 | 158 | 0.150 |
Why?
| | Mice, Knockout, ApoE | 1 | 2018 | 11 | 0.140 |
Why?
| | Immunohistochemistry | 4 | 2022 | 1738 | 0.140 |
Why?
| | Aorta, Thoracic | 2 | 2007 | 267 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 1994 | 55 | 0.140 |
Why?
| | Hyperplasia | 1 | 2018 | 175 | 0.140 |
Why?
| | Extracellular Matrix | 1 | 2021 | 528 | 0.140 |
Why?
| | Endothelium, Vascular | 3 | 2018 | 927 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2019 | 243 | 0.130 |
Why?
| | Collagen | 1 | 1999 | 452 | 0.130 |
Why?
| | Myocardial Ischemia | 1 | 2018 | 263 | 0.130 |
Why?
| | Promoter Regions, Genetic | 4 | 2020 | 1250 | 0.120 |
Why?
| | Serum Response Factor | 1 | 2016 | 33 | 0.120 |
Why?
| | Disease Models, Animal | 4 | 2022 | 4295 | 0.120 |
Why?
| | Male | 12 | 2023 | 67762 | 0.120 |
Why?
| | Heart | 2 | 2018 | 655 | 0.110 |
Why?
| | Ventricular Function, Left | 1 | 2018 | 534 | 0.110 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2011 | 3715 | 0.110 |
Why?
| | Cells, Cultured | 7 | 2022 | 4193 | 0.110 |
Why?
| | Macrophages, Peritoneal | 1 | 1994 | 94 | 0.110 |
Why?
| | Proto-Oncogene Proteins | 2 | 1994 | 648 | 0.110 |
Why?
| | Transcription Factors | 3 | 2023 | 1719 | 0.110 |
Why?
| | Membrane Proteins | 3 | 1995 | 1164 | 0.110 |
Why?
| | Stem Cells | 3 | 2023 | 594 | 0.100 |
Why?
| | Lymphatic Vessels | 1 | 2014 | 64 | 0.100 |
Why?
| | Mice, Transgenic | 5 | 2020 | 2167 | 0.100 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2004 | 545 | 0.100 |
Why?
| | Female | 9 | 2023 | 73304 | 0.100 |
Why?
| | Endostatins | 2 | 2004 | 10 | 0.100 |
Why?
| | Genes | 1 | 1992 | 230 | 0.090 |
Why?
| | Cell Adhesion Molecules | 1 | 1992 | 181 | 0.090 |
Why?
| | Rats | 3 | 2019 | 5647 | 0.090 |
Why?
| | Encephalocele | 1 | 2010 | 10 | 0.090 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2010 | 26 | 0.090 |
Why?
| | Humans | 17 | 2023 | 137585 | 0.090 |
Why?
| | Retinal Degeneration | 1 | 2010 | 38 | 0.080 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 156 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 2 | 2016 | 2486 | 0.080 |
Why?
| | Retinal Detachment | 1 | 2010 | 63 | 0.080 |
Why?
| | DNA-Binding Proteins | 2 | 1994 | 1502 | 0.080 |
Why?
| | MAP Kinase Kinase Kinase 3 | 1 | 2009 | 4 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 283 | 0.080 |
Why?
| | Simvastatin | 1 | 2009 | 61 | 0.080 |
Why?
| | In Vitro Techniques | 3 | 2004 | 1092 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 976 | 0.070 |
Why?
| | Middle Aged | 3 | 2021 | 33479 | 0.070 |
Why?
| | Aged | 2 | 2018 | 23961 | 0.070 |
Why?
| | Triglycerides | 1 | 2010 | 524 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 852 | 0.070 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2009 | 140 | 0.070 |
Why?
| | Profilins | 1 | 2007 | 3 | 0.070 |
Why?
| | Cholesterol | 2 | 2023 | 410 | 0.070 |
Why?
| | Receptors, Scavenger | 4 | 1995 | 23 | 0.070 |
Why?
| | Vasculitis | 1 | 2007 | 66 | 0.070 |
Why?
| | Biomarkers | 2 | 2022 | 4149 | 0.060 |
Why?
| | Angiotensin II | 2 | 2019 | 99 | 0.060 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 445 | 0.060 |
Why?
| | Adult | 2 | 2018 | 37929 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 143 | 0.060 |
Why?
| | Diet, Atherogenic | 1 | 2004 | 6 | 0.060 |
Why?
| | Cholesterol, Dietary | 1 | 2004 | 18 | 0.060 |
Why?
| | E-Selectin | 1 | 2004 | 57 | 0.050 |
Why?
| | Organ Culture Techniques | 1 | 2004 | 156 | 0.050 |
Why?
| | Corn Oil | 1 | 2023 | 5 | 0.050 |
Why?
| | Gene Dosage | 1 | 2004 | 140 | 0.050 |
Why?
| | Angiostatins | 1 | 2003 | 3 | 0.050 |
Why?
| | Proprotein Convertase 9 | 1 | 2023 | 73 | 0.050 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2003 | 79 | 0.050 |
Why?
| | Endothelial Growth Factors | 1 | 2003 | 64 | 0.050 |
Why?
| | Plasminogen | 1 | 2003 | 30 | 0.050 |
Why?
| | Lymphokines | 1 | 2003 | 131 | 0.050 |
Why?
| | Muscle, Smooth | 1 | 2023 | 155 | 0.050 |
Why?
| | Blotting, Western | 2 | 2019 | 1226 | 0.050 |
Why?
| | Chemokine CCL2 | 1 | 2003 | 115 | 0.050 |
Why?
| | Angiogenesis Inhibitors | 1 | 2004 | 229 | 0.050 |
Why?
| | Feedback | 1 | 2003 | 173 | 0.050 |
Why?
| | Neointima | 1 | 2022 | 15 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2023 | 165 | 0.050 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.050 |
Why?
| | Long Term Adverse Effects | 1 | 2021 | 12 | 0.050 |
Why?
| | ADAMTS4 Protein | 1 | 2021 | 16 | 0.050 |
Why?
| | Cell Nucleus | 3 | 1994 | 620 | 0.050 |
Why?
| | DNA Helicases | 1 | 2023 | 145 | 0.050 |
Why?
| | Base Sequence | 3 | 1994 | 2181 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2003 | 382 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2004 | 518 | 0.040 |
Why?
| | Scavenger Receptors, Class B | 3 | 1995 | 14 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 1994 | 2900 | 0.040 |
Why?
| | Endothelial Cells | 2 | 2022 | 785 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 93 | 0.040 |
Why?
| | Monocytes | 1 | 2003 | 563 | 0.040 |
Why?
| | Skin | 1 | 2004 | 752 | 0.040 |
Why?
| | Mutation | 1 | 2010 | 3958 | 0.040 |
Why?
| | Cyclohexanes | 1 | 1999 | 21 | 0.040 |
Why?
| | Swine | 1 | 2022 | 775 | 0.040 |
Why?
| | Azacitidine | 1 | 2020 | 140 | 0.040 |
Why?
| | Chromatin | 1 | 2023 | 519 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 452 | 0.040 |
Why?
| | Aortic Valve Stenosis | 1 | 2022 | 229 | 0.040 |
Why?
| | Arteries | 1 | 2020 | 269 | 0.040 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 192 | 0.040 |
Why?
| | Cell Count | 1 | 1999 | 324 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 660 | 0.040 |
Why?
| | Homeostasis | 1 | 2022 | 621 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2023 | 712 | 0.040 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 1995 | 91 | 0.040 |
Why?
| | Cell Division | 1 | 1999 | 794 | 0.030 |
Why?
| | DNA | 2 | 1994 | 1459 | 0.030 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1994 | 150 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1178 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2071 | 0.030 |
Why?
| | Foam Cells | 1 | 1995 | 18 | 0.030 |
Why?
| | Transcriptome | 1 | 2022 | 971 | 0.030 |
Why?
| | Gene Targeting | 1 | 1995 | 81 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 13209 | 0.030 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 1994 | 11 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor Receptor-3 | 1 | 2014 | 7 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 1994 | 56 | 0.030 |
Why?
| | Apolipoproteins B | 1 | 2014 | 43 | 0.030 |
Why?
| | Signal Transduction | 3 | 2022 | 5079 | 0.030 |
Why?
| | Luciferases | 1 | 1994 | 150 | 0.030 |
Why?
| | Substrate Specificity | 1 | 1994 | 372 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1994 | 375 | 0.030 |
Why?
| | RNA | 1 | 2019 | 921 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 1994 | 190 | 0.020 |
Why?
| | HeLa Cells | 1 | 1994 | 636 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 1994 | 955 | 0.020 |
Why?
| | Adolescent | 1 | 2011 | 21513 | 0.020 |
Why?
| | Transfection | 1 | 1994 | 945 | 0.020 |
Why?
| | Sequence Alignment | 1 | 1992 | 343 | 0.020 |
Why?
| | Inflammation | 1 | 2003 | 2837 | 0.020 |
Why?
| | Radio Waves | 1 | 1991 | 18 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1992 | 534 | 0.020 |
Why?
| | Atrioventricular Node | 1 | 1991 | 15 | 0.020 |
Why?
| | Child | 1 | 2011 | 21935 | 0.020 |
Why?
| | Trans-Activators | 1 | 1994 | 398 | 0.020 |
Why?
| | Electrodes | 1 | 1991 | 114 | 0.020 |
Why?
| | Repressor Proteins | 1 | 1994 | 427 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2009 | 56 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 672 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2009 | 132 | 0.020 |
Why?
| | Renin-Angiotensin System | 1 | 2009 | 85 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 353 | 0.020 |
Why?
| | Benzamides | 1 | 2009 | 216 | 0.020 |
Why?
| | Cell Line | 1 | 1994 | 2847 | 0.020 |
Why?
| | Time Factors | 1 | 1999 | 6828 | 0.020 |
Why?
| | RNA, Messenger | 2 | 1994 | 2833 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 816 | 0.020 |
Why?
| | Cardiac Catheterization | 1 | 1991 | 530 | 0.020 |
Why?
| | CD36 Antigens | 1 | 2007 | 36 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 39 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2007 | 173 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2007 | 116 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2007 | 204 | 0.020 |
Why?
| | Heterozygote | 1 | 2007 | 293 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1992 | 1457 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 1991 | 530 | 0.010 |
Why?
| | HL-60 Cells | 1 | 2004 | 34 | 0.010 |
Why?
| | Transduction, Genetic | 1 | 2004 | 127 | 0.010 |
Why?
| | Cornea | 1 | 2004 | 138 | 0.010 |
Why?
| | Neovascularization, Physiologic | 1 | 2004 | 179 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 466 | 0.010 |
Why?
| | Leukocytes | 1 | 2004 | 311 | 0.010 |
Why?
| | Gene Deletion | 1 | 2004 | 391 | 0.010 |
Why?
| | Blood Pressure | 1 | 2009 | 1786 | 0.010 |
Why?
| | Aorta | 1 | 2004 | 417 | 0.010 |
Why?
| | Cell Movement | 1 | 2004 | 967 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 1946 | 0.010 |
Why?
| | Cytokines | 1 | 2004 | 2085 | 0.010 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1994 | 4 | 0.010 |
Why?
| | Genes, jun | 1 | 1994 | 10 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 1994 | 229 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1994 | 1353 | 0.010 |
Why?
| | Postoperative Period | 1 | 1991 | 342 | 0.010 |
Why?
| | Equipment Design | 1 | 1991 | 522 | 0.000 |
Why?
| | Myocardium | 1 | 1991 | 1002 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1991 | 5131 | 0.000 |
Why?
|
|
Moulton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|